See also this year's filing and all EDGAR filings for this company.
PDF Report 0001070494_2020_ACADIA_PHARMACEUTICALS_INC.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001070494, ACADIA PHARMACEUTICALS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 760,250,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 2,585,000 |
| 2 | PropertyPlantAndEquipmentNet | 3,180,000 |
| 3 | remainder_Assets | 17,168,000 |
| 4 | LiabilitiesCurrent | 74,826,000 |
| 5 | LiabilitiesNoncurrent | 9,222,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 11,344,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 325,638,000 |
| 9 | ResearchAndDevelopmentExpense | 240,385,000 |
| 10 | remainder_Expenses | 9,130,000 |
| 11 | remainder_Revenues | 339,076,000 |
| 12 | remainder_NetIncome | 12,162,000 |
| 13 | remainder_ComprehensiveNetIncome | 669,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 783,183,000 |
| 1 | Liabilities | 84,048,000 |
| 2 | Expenses | 586,497,000 |
| 3 | Revenues | 339,076,000 |
| 4 | StockholdersEquity | 699,135,000 |
| 5 | NetIncome | -235,259,000 |
| 6 | ComprehensiveNetIncome | -234,924,500 |
| 7 | BaseVar | 902,817,500 |
| 8 | EconomicCapitalRatio | 2.23 |
Edgar->Model Mapping
Feature Distribution
Change over Time
